Manufacture

Gene is in charge of seed train duty! But the reality doesn’t quite live up to his expectations…

When it comes to the crunch – the swab test – planning and preparation are the key to the best performance.

The Medicine Maker speaks with Oskar Gold of Vetter

The supply of cell and gene therapies is a delicate operation – and easily broken, just like daisy chains.

What lies ahead for Gene and Eva in 2019? Cell and gene therapies!

How a collaborative project aims to cut the cost of gene therapy

Serialization will certainly help in the battle against counterfeiters, but there are other steps that manufacturers can take.

It’s time for pharma to leave behind the highly energy-dependent and inflexible processes of the 20th century. Let’s “biologicalize” manufacturing.

Why use a huge manufacturing facility when biological medicines can be made in a suitcase?

The stem cell industry needs to embrace bioprocess control systems to develop consistent, high quality, and commercially viable bioprocesses.